BoomerangFX Launches ChatGPT AI Search Advertising
New offering connects paid search advertising on OpenAI's ChatGPT with AI search optimisation for Claude and Gemini.
Topics
BoomerangFX, the global AI-powered clinic software and marketing automation company purpose-built for private-pay healthcare, has announced the launch of its next-generation AI Search Marketing offering.
Rolling out first in the USA, Canada and the UK beginning November 2026, the launch brings AI Search Advertising on OpenAI’s ChatGPT and Search Optimization Intelligence for Claude and Gemini into its GROW SaaS product suite, enhanced by AUVIA, the AI Clinic Co-Pilot, connecting patient inquiries to conversion and end-to-end clinic practice management.
BoomerangFX describes its speciality AI search marketing platform as connecting ChatGPT ad campaigns, Claude and Gemini optimisation, and agentic patient engagement with integrated electronic medical records, scheduling, and payments. The offering is available through the GROW Platinum upgrade for existing and new clients.
ALSO READ: 1,006 Patients Were Asked About AI. Where Should Healthcare Draw the Line?
A New Era of Patient Discovery: AI Assistants Become the Front Door to Care
AI assistants are fast becoming a starting point for treatment research by prospective shoppers for aesthetic and wellness treatments. According to an August 2026 Pew Research Center report, 34% of U.S. adults now use AI chatbots for at least one health or medical reason. BoomerangFX helps practices build visibility in these emerging discovery channels and convert that interest into booked consultations.
“The next era of clinic growth will be shaped by how effectively practices turn AI discovery into lasting patient relationships,” said Jerome Dwight, Co-Founder & CEO of BoomerangFX. “We are bringing advertising, search visibility, patient conversations and clinical operations into one platform, helping clinics connect the demand they create with the experience they deliver.”
Smart Website Intelligence: Making AI Discovery Actionable
The GROW product suite’s Smart Website Intelligence provides the foundation for AI discoverability, organising treatment expertise, clinician credentials, practice locations and patient education into clear, accessible website content.
Search Optimization Intelligence applies BoomerangFX’s proprietary data science to help AI platforms discover, interpret and reference that information when prospective patients research care.
The offering combines eligible paid AI Search Ads on OpenAI’s ChatGPT with website and content optimisation for organic discoverability through Claude and Gemini, giving every visitor a clear pathway to inquire, engage and book. For greater discoverability, the Company’s multi-platform advertising model also leverages more conventional platforms like Google, Meta and Instagram for maximum reach.
ALSO READ: Semrush Joins Vibe Marketing Tech Fest Singapore 2026 as Silver Sponsor
Additionally, its AI-powered Clinic Co-Pilot AUVIA’s agentic workflows support immediate lead response and personalised follow-up to move inquiries into booked treatments with minimal manual intervention. Campaign and conversion signals feed ongoing optimisation, linking marketing activity directly to patient engagement and booking outcomes.
The BoomerangFX Platform: One System From First Inquiry to Lifetime Patient Care
BoomerangFX connects this new channel to three integrated solutions:
- RUN: The all-in-one practice management and EMR foundation. Scheduling, digital charting, consents, treatment records, e-prescribing, inventory and reporting connect with billing, payments and patient financing, while memberships, packages and rebooking sustain long-term patient relationships. The Company’s product roadmap includes agentic workflows inside the system of record to drive clinic optimisation and task management for busy clinics.
- GROW: Lead capture, pipeline management, Smart Website Intelligence and conversion workflows. Once demand is created through optimised advertising campaigns, AUVIA, its specialised multi-LLM AI Clinic Co-Pilot, engages prospective patients through personalised multilingual chat features, coordinates qualification and consultation booking, supports payment workflows and automates reminders and follow-up.
- ELEVATE: The firm’s speciality marketing strategy and execution generate demand, connecting speciality positioning, intelligent website optimisation, campaign development, paid media and ongoing optimisation to each practice’s growth objectives.
ALSO READ: Marquee Awards Recognises Marketing Excellence at Gala Celebration
Together, these solutions carry the relationship from first inquiry through engagement and into RUN for treatment documentation, compliance, payments and ongoing care. Practice owners gain a coordinated operating model designed to improve conversion, reduce missed inquiries and increase the lifetime value of every patient.
Built on Speciality Data Science and Clinical Expertise
The launch builds on the BoomerangFX team’s experience delivering more than 10,000 Google, Meta and Instagram campaigns over the past decade. Its proprietary machine learning and data science models combine that marketing experience with speciality context and performance analysis to inform campaign development and optimisation.
AUVIA’s speciality knowledge framework spans in excess of 2,000 speciality treatment and clinical-indication entries, covering procedural nomenclature, treatment modalities and concerns such as cutaneous photodamage, dermal laxity and dyspigmentation. This context supports relevant patient communication, while clinical assessment and treatment selection remain with the practitioner.
Leadership in Aesthetics Innovation and Clinical Education
Clinical guidance is informed by BoomerangFX’s medical advisory board, led by Dr. Stephen Mulholland, Co-Founder and Chief Clinical Architect of BoomerangFX. A globally recognised cosmetic surgeon, Dr. Mulholland is a co-founder of InMode, where he helped lead its 2019 NASDAQ IPO, co-creator of Morpheus8 and co-developer of BodyTite, FaceTite and AccuTite.
“Aesthetic and wellness practices need technology that understands the language of their specialities and the expectations of their patients,” said Dr. Stephen Mulholland, Co-Founder and Chief Clinical Architect of BoomerangFX.
“Connecting speciality-level marketing with responsive communication and a complete clinical record helps practices deliver a more consistent experience from the first question through continuing care.”
ALSO READ: Is Your Website Still Playing Twenty Questions?
Availability: Rollout Beginning November 2026
The offering launches in November 2026 through its GROW Platinum Tier, beginning in the USA, Canada and the UK, with expansion planned across Ireland, Germany, Australia, India and Latin America.
Upgrade pathways are available for existing BoomerangFX RUN and GROW clients. The launch extends BoomerangFX’s recurring subscription platform across patient acquisition, AI engagement, clinical software and payments.
ChatGPT ad activation depends on market availability, practice speciality, and advertiser approval. Search Optimization Intelligence supports organic discoverability on Claude and Gemini; inclusion, rankings and recommendations remain determined by each platform. Paid placements are separate from AI-generated answers.